Literature DB >> 17484074

Antifungal susceptibility profiles of Coccidioides immitis and Coccidioides posadasii from endemic and non-endemic areas.

Rama Ramani1, Vishnu Chaturvedi.   

Abstract

Coccidioidomycosis is a systemic fungal infection endemic in Southwestern United States, Mexico, Central and South America. The causal agents are Coccidioides immitis and C. posadasii. A large number of cases of coccidioidomycosis in New York State residents were identified. We compared susceptibility profiles of these isolates and of C. immitis isolates from California using mycelial phase inoculum and CLSI (NCCLS) M38-A broth microdilution protocol. Minimum fungicidal concentrations (MFC) were also determined. Results indicated that geometric mean MICs of amphotericin B (AMB, 0.06 microg/ml), fluconazole (FLC, 8.0 microg/ml), itraconazole (ITC, 0.07 microg/ml), ketoconazole (KTC, 0.04 microg/ml), voriconazole (VRC, 0.04 microg/ml), posaconazole (PSC, 0.17 microg/ml) and caspofungin (CSP, 0.15 microg/ml) were in susceptible range as per breakpoints published for pathogenic Candida species. However, geometric MFC for FLC was relatively higher (52.4 microg/ml). Also, no significant difference in MIC and MFC values was evident for C. immitis and C. posadasii isolates. In conclusion, current methods for antifungal susceptibility testing yield reproducible profiles for Coccidioides species, which appear to be highly susceptible to most antifungal agents.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17484074     DOI: 10.1007/s11046-007-9018-7

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   3.785


  19 in total

Review 1.  Female genital coccidioidomycosis (FGC), Addison's disease and sigmoid loop abscess due to Coccidioides immites; case report and review of literature on FGC.

Authors:  A Chowfin; R Tight
Journal:  Mycopathologia       Date:  1999       Impact factor: 2.574

2.  Correlation between antifungal susceptibilities of Coccidioides immitis in vitro and antifungal treatment with caspofungin in a mouse model.

Authors:  G M González; R Tijerina; L K Najvar; R Bocanegra; M Luther; M G Rinaldi; J R Graybill
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

3.  Coccidioidomycosis diagnosed in South Carolina.

Authors:  J Blake Long; Allan S Brett; Joseph A Horvath
Journal:  South Med J       Date:  2005-09       Impact factor: 0.954

4.  Refractory coccidioidomycosis treated with posaconazole.

Authors:  Gregory M Anstead; Gavin Corcoran; James Lewis; Deborah Berg; John R Graybill
Journal:  Clin Infect Dis       Date:  2005-05-13       Impact factor: 9.079

5.  In vitro activities of voriconazole, itraconazole, and amphotericin B against Blastomyces dermatitidis, Coccidioides immitis, and Histoplasma capsulatum.

Authors:  R K Li; M A Ciblak; N Nordoff; L Pasarell; D W Warnock; M R McGinnis
Journal:  Antimicrob Agents Chemother       Date:  2000-06       Impact factor: 5.191

6.  Molecular and phenotypic description of Coccidioides posadasii sp. nov., previously recognized as the non-California population of Coccidioides immitis.

Authors:  M C Fisher; G L Koenig; T J White; J W Taylor
Journal:  Mycologia       Date:  2002 Jan-Feb       Impact factor: 2.696

Review 7.  Unusual case of pyopneumothorax in Tennessee.

Authors:  Souad S Youssef; Vijay Ramu; Felix A Sarubbi
Journal:  South Med J       Date:  2005-11       Impact factor: 0.954

8.  Disseminated coccidioidomycosis in an immunocompetent person living in New York City.

Authors:  Amy Chuang; Reeni Thomas; Robert S Hoffman
Journal:  J Urban Health       Date:  2005-05-12       Impact factor: 3.671

9.  Comparison of Sensititre YeastOne with the NCCLS M38-A microdilution method to determine the activity of amphotericin B, voriconazole, and itraconazole against clinical isolates of Aspergillus fumigatus.

Authors:  Jesús Guinea; Teresa Peláez; Luis Alcalá; Emilio Bouza
Journal:  Diagn Microbiol Infect Dis       Date:  2006-05-02       Impact factor: 2.803

10.  Coccidioides immitis isolated from armadillos (Dasypus novemcinctus) in the state of Piauí, northeast Brazil.

Authors:  K D Eulálio; R L de Macedo; M A Cavalcanti; L M Martins; M S Lazéra; B Wanke
Journal:  Mycopathologia       Date:  2001       Impact factor: 3.785

View more
  16 in total

1.  Arthroconidia in lung tissue: an unusual histopathological finding in pulmonary coccidioidomycosis.

Authors:  Thea Brennan-Krohn; Edward Yoon; Michiya Nishino; James E Kirby; Stefan Riedel
Journal:  Hum Pathol       Date:  2017-08-01       Impact factor: 3.466

2.  Onygenalean Fungi as Major Human and Animal Pathogens.

Authors:  Vishnu Chaturvedi; G Sybren de Hoog
Journal:  Mycopathologia       Date:  2020-02       Impact factor: 2.574

3.  Antifungal therapeutics for dimorphic fungal pathogens.

Authors:  Kristie D Goughenour; Chad A Rappleye
Journal:  Virulence       Date:  2016-09-19       Impact factor: 5.882

4.  Large-Scale Evaluation of In Vitro Amphotericin B, Triazole, and Echinocandin Activity against Coccidioides Species from U.S. Institutions.

Authors:  George R Thompson; Bridget M Barker; Nathan P Wiederhold
Journal:  Antimicrob Agents Chemother       Date:  2017-03-24       Impact factor: 5.191

5.  The Novel Fungal Cyp51 Inhibitor VT-1598 Is Efficacious in Experimental Models of Central Nervous System Coccidioidomycosis Caused by Coccidioides posadasii and Coccidioides immitis.

Authors:  Nathan P Wiederhold; Lisa F Shubitz; Laura K Najvar; Rosie Jaramillo; Marcos Olivo; Gabriel Catano; Hien T Trinh; Christopher M Yates; Robert J Schotzinger; Edward P Garvey; Thomas F Patterson
Journal:  Antimicrob Agents Chemother       Date:  2018-03-27       Impact factor: 5.191

6.  In Vitro Evaluation of Antifungal Drug Combinations against Multidrug-Resistant Candida auris Isolates from New York Outbreak.

Authors:  Brittany O'Brien; Sudha Chaturvedi; Vishnu Chaturvedi
Journal:  Antimicrob Agents Chemother       Date:  2020-03-24       Impact factor: 5.191

7.  Efficacy of the Investigational Antifungal VT-1161 in Treating Naturally Occurring Coccidioidomycosis in Dogs.

Authors:  Lisa F Shubitz; Michael E Roy; Hien T Trinh; William J Hoekstra; Robert J Schotzinger; Edward P Garvey
Journal:  Antimicrob Agents Chemother       Date:  2017-04-24       Impact factor: 5.191

8.  Voriconazole use for endemic fungal infections.

Authors:  Alison Freifeld; Laurie Proia; David Andes; Larry M Baddour; Janis Blair; Brad Spellberg; Sandra Arnold; Arnold Lentnek; L Joseph Wheat
Journal:  Antimicrob Agents Chemother       Date:  2009-01-12       Impact factor: 5.191

9.  Pharmacokinetics of nikkomycin Z after single rising oral doses.

Authors:  David E Nix; Robert R Swezey; Richard Hector; John N Galgiani
Journal:  Antimicrob Agents Chemother       Date:  2009-04-06       Impact factor: 5.191

10.  Intrapulmonary pharmacokinetics and pharmacodynamics of posaconazole at steady state in healthy subjects.

Authors:  John E Conte; Jeffrey A Golden; Gopal Krishna; Marina McIver; Emily Little; Elisabeth Zurlinden
Journal:  Antimicrob Agents Chemother       Date:  2008-11-24       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.